GlassScriptPhysician profile
Kyle R Marden
NPI 1942795802
$1,207.91
in general payments reported to CMS, 2019-2025
11 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
See the full distribution for Neuromuscular Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $475 · 2022: $244 · 2023: $235 · 2024: $153 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $257.47 | 2021 | |
| Abbvie INC. | $218.99 | 2022-2025 | |
| Ucb, INC. | $120.00 | 2024 | Rystiggo |
| Livanova USA, INC. | $112.02 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Astrazeneca Pharmaceuticals LP | $111.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $110.75 | 2022 | |
| Sk Life Science, INC. | $108.72 | 2023 | Xcopri |
| Alexion Pharmaceuticals, INC. | $105.93 | 2021 | |
| Boston Scientific Corporation | $32.94 | 2022 | |
| Medtronic, INC. | $14.74 | 2023 | Linq II |
| Philips North America LLC | $14.73 | 2024 | (5044) Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Marden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.